|
1
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI
|
|
2
|
Kostoff RN, Briggs MB, Porter AL, Aschner
M, Spandidos DA and Tsatsakis A: [Editorial] COVID-19:
Post-lockdown guidelines. Int J Mol Med. 46:463–466. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goumenou M, Sarigiannis D, Tsatsakis A,
Anesti O, Docea AO, Petrakis D, Tsoukalas D, Kostoff R, Rakitskii
V, Spandidos DA, et al: COVID-19 in Northern Italy: An integrative
overview of factors possibly influencing the sharp increase of the
outbreak (Review). Mol Med Rep. 22:20–32. 2020.PubMed/NCBI
|
|
4
|
Kostoff RN, Briggs MB, Porter AL,
Hernández AF, Abdollahi M, Aschner M and Tsatsakis A: The
under-reported role of toxic substance exposures in the COVID-19
pandemic. Food Chem Toxicol. 145:1116872020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Farsalinos K, Niaura R, Le Houezec J,
Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A and Poulas K:
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of
the nicotinic cholinergic system. Toxicol Rep. 7:658–663. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Skalny AV, Rink L, Ajsuvakova OP, Aschner
M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos
DA, Aaseth J, et al: Zinc and respiratory tract infections:
Perspectives for COVID-19 (Review). Int J Mol Med. 46:17–26.
2020.PubMed/NCBI
|
|
7
|
Nitulescu GM, Paunescu H, Moschos SA,
Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK,
Drakoulis N and Tsatsakis A: Comprehensive analysis of drugs to
treat SARS-CoV-2 infection: Mechanistic insights into current
COVID-19 therapies (Review). Int J Mol Med. 46:467–488. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stancioiu F, Papadakis GZ, Kteniadakis S,
Izotov BN, Coleman MD, Spandidos DA and Tsatsakis A: A dissection
of SARS-CoV2 with clinical implications (Review). Int J Mol Med.
46:489–508. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Torequl Islam M, Nasiruddin M, Khan IN,
Mishra SK, Kudrat-E-Zahan M, Alam Riaz T, Ali ES, Rahman MS,
Mubarak MS, Martorell M, et al: A perspective on emerging
therapeutic interventions for COVID-19. Front Public Health.
8:2812020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arsene AL, Dumitrescu IB, Dragoi CM,
Udeanu DI, Lupuliasa D, Jinga V, Draganescu D, Dinu-Pirvu CE,
Dragomiroiu G, Blejan IE, et al: A new era for the therapeutic
management of the ongoing Covid-19 pandemic. Farmacia. 68:185–196.
2020. View Article : Google Scholar
|
|
11
|
Dehelean CA, Lazureanu V, Coricovac D,
Mioc M, Oancea R, Marcovici I, Pinzaru I, Soica C, Tsatsakis AM and
Cretu O: SARS-CoV-2: Repurposed drugs and novel therapeutic
approaches -insights into chemical structure-biological activity
and toxicological screening. J Clin Med. 9:20842020. View Article : Google Scholar
|
|
12
|
Teslya A, Pham TM, Godijk NG, Kretzschmar
ME, Bootsma MCJ and Rozhnova G: Impact of self-imposed prevention
measures and short-term government-imposed social distancing on
mitigating and delaying a COVID-19 epidemic: A modelling study.
PLoS Med. 17:e10031662020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nazarenko Y: Air filtration and
SARS-CoV-2. Epidemiol Health. 42:e20200492020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fathizadeh H, Maroufi P, Momen-Heravi M,
Dao S, Köse Ş, Ganbarov K, Pagliano P, Esposito S and Kafil HS:
Protection and disinfection policies against SARS-CoV-2 (COVID-19).
Infez Med. 28:185–191. 2020.PubMed/NCBI
|
|
15
|
Li Y, Tokura H, Guo YP, Wong AS, Wong T,
Chung J and Newton E: Effects of wearing N95 and surgical facemasks
on heart rate, thermal stress and subjective sensations. Int Arch
Occup Environ Health. 78:501–509. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lazzarino AI, Steptoe A, Hamer M and
Michie S: Covid-19: Important potential side effects of wearing
face masks that we should bear in mind. BMJ. 369:m20032020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
HHS.gov: Fact Sheet: Explaining Operation
Warp Speed. https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.htmluri
Accessed June 16, 2020.
|
|
18
|
Craven J: COVID-19 vaccine tracker.
Regulatory Affairs Professionals Society; Rockville, MD: 2020,
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-trackeruri.
Accessed September 10, 2020.
|
|
19
|
Calina D, Docea AO, Petrakis D, Egorov A
M, Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff RN, Carvalho
F, Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aschner M: Are we rushing too much? Food
Chem Toxicol. 143:1115512020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kostoff RN, Goumenou M and Tsatsakis A:
The role of toxic stimuli combinations in determining safe exposure
limits. Toxicol Rep. 5:1169–1172. 2018. View Article : Google Scholar
|
|
22
|
Tsatsakis A, Petrakis D, Nikolouzakis TK,
Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis
C, Aschner M and Hernández AF: COVID-19, an opportunity to
reevaluate the correlation between long-term effects of
anthropogenic pollutants on viral epidemic/pandemic events and
prevalence. Food Chem Toxicol. 141:1114182020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hernández AF and Tsatsakis AM: Human
exposure to chemical mixtures: Challenges for the integration of
toxicology with epidemiology data in risk assessment. Food Chem
Toxicol. 103:188–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsatsakis AM, Kouretas D, Tzatzarakis MN,
Stivaktakis P, Tsarouhas K, Golokhvast KS, Rakitskii VN, Tutelyan
VA, Hernandez AF, Rezaee R, et al: Simulating real-life exposures
to uncover possible risks to human health: A proposed consensus for
a novel methodological approach. Hum Exp Toxicol. 36:554–564. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsatsakis AM, Docea AO and Tsitsimpikou C:
New challenges in risk assessment of chemicals when simulating real
exposure scenarios; simultaneous multi-chemicals' low dose
exposure. Food Chem Toxicol. 96:174–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Benn CS, Netea MG, Selin LK and Aaby P: A
small jab - a big effect: Nonspecific immunomodulation by vaccines.
Trends Immunol. 34:431–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kostoff RN, Aschner M, Goumenou M and
Tsatsakis A: Setting safer exposure limits for toxic substance
combinations. Food Chem Toxicol. 140:1113462020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sergievich AA, Khoroshikh PP, Artemenko
AF, Zakharenko AM, Chaika VV, Kodintsev VV, Stroeva OA, Lenda EG,
Tsatsakis A, Burykina TI, et al: Behavioral impacts of a mixture of
six pesticides on rats. Sci Total Environ. 727:1384912020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fountoucidou P, Veskoukis AS, Kerasioti E,
Docea AO, Taitzoglou IA, Liesivuori J, Tsatsakis A and Kouretas D:
A mixture of routinely encountered xenobiotics induces both redox
adaptations and perturbations in blood and tissues of rats after a
long-term low-dose exposure regimen: The time and dose issue.
Toxicol Lett. 317:24–44. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsatsakis A, Docea AO, Constantin C,
Calina D, Zlatian O, Nikolouzakis TK, Stivaktakis PD, Kalogeraki A,
Liesivuori J, Tzanakakis G, et al: Genotoxic, cytotoxic, and
cytopathological effects in rats exposed for 18 months to a mixture
of 13 chemicals in doses below NOAEL levels. Toxicol Lett.
316:154–170. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsatsakis A, Tyshko NV, Docea AO,
Shestakova SI, Sidorova YS, Petrov NA, Zlatian O, Mach M, Hartung T
and Tutelyan VA: The effect of chronic vitamin deficiency and long
term very low dose exposure to 6 pesticides mixture on neurological
outcomes - A real-life risk simulation approach. Toxicol Lett.
315:96–106. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Docea AO, Gofita E, Goumenou M, Calina D,
Rogoveanu O, Varut M, Olaru C, Kerasioti E, Fountoucidou P,
Taitzoglou I, et al: Six months exposure to a real life mixture of
13 chemicals' below individual NOAELs induced non monotonic
sex-dependent biochemical and redox status changes in rats. Food
Chem Toxicol. 115:470–481. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Docea AO, Goumenou M, Calina D, Arsene AL,
Dragoi CM, Gofita E, Pisoschi CG, Zlatian O, Stivaktakis PD,
Nikolouzakis TK, et al: Adverse and hormetic effects in rats
exposed for 12 months to low dose mixture of 13 chemicals: RLRS
part III. Toxicol Lett. 310:70–91. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsatsakis AM, Docea AO, Calina D, Buga AM,
Zlatian O, Gutnikov S, Kostoff RN and Aschner M: Hormetic
neuro-behavioral effects of low dose toxic chemical mixtures in
real-life risk simulation (RLRS) in rats. Food Chem Toxicol.
125:141–149. 2019. View Article : Google Scholar
|
|
35
|
Agmon-Levin N, Paz Z, Israeli E and
Shoenfeld Y: Vaccines and autoimmunity. Nat Rev Rheumatol.
5:648–652. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mikaeloff Y, Caridade G, Suissa S and
Tardieu M: Hepatitis B vaccine and the risk of CNS inflammatory
demyelination in childhood. Neurology. 72:873–880. 2009. View Article : Google Scholar
|
|
37
|
Classen JB and Classen DC: Clustering of
cases of insulin dependent diabetes (IDDM) occurring three years
after hemophilus influenza B (HiB) immunization support causal
relationship between immunization and IDDM. Autoimmunity.
35:247–253. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Institute for Vaccine Safety, Johns
Hopkins Bloomberg School of Public Health: Package inserts and
manufacturers for some US licensed vaccines and immunoglobulins.
https://www.vaccine-safety.edu/package_inserts.htmuri.
Last update June 30, 2020.
|
|
39
|
Kostoff RN: Under-reporting of Adverse
Events in the Biomedical Literature. J Data Inf Sci. 1:10–32.
2017.
|
|
40
|
Calina D, Hartung T, Docea AO, Spandidos
DA, Egorov AM, Shtilman MI, Carvalho F and Tsatsakis A: COVID-19
vaccines: Ethical framework concerning human challenge studies.
Daru. Aug 27–2020.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maragakis LL: Coronavirus Disease: 2019
vs. the Flu. Johns Hopkins Medicine. 2020. https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-disease-2019-vs-the-fluuri.
Updated September 16, 2020.
|
|
42
|
Jackson LA, Anderson EJ, Rouphael NG,
Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD,
Denison MR, Stevens LJ, et al: An mRNA vaccine against SARS-CoV-2 -
preliminary report. N Engl J Med. Jul 14–2020.Epub ahead of print.
View Article : Google Scholar
|
